Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Transmedics Group Inc shares valued at $131,278 were sold by Khayal Tamer I on Nov 11 ’24. At $90.04 per share, Khayal Tamer I sold 1,458 shares. The insider’s holdings dropped to 20,843 shares worth approximately $1.93 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Basile Edward M sold 6,750 shares, netting a total of over 563,994 in proceeds. Following the sale of shares at $83.55 each, the insider now holds 732 shares.
Before that, Khayal Tamer I had sold 1,083 shares from its account. In a trade valued at $89,499, the Chief Commercial Officer traded Transmedics Group Inc shares for $82.64 each. Upon closing the transaction, the insider’s holdings decreased to 1,083 shares, worth approximately $1.93 million.
As published in a research note from Oppenheimer on October 29, 2024, Transmedics Group Inc [TMDX] has been retained to an Outperform and the price target has been revised to $125. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in late October. As of September 24, 2024, Robert W. Baird has initiated its “an Outperform” rating for TMDX. Earlier on August 21, 2024, Needham initiated its rating. Their recommendation was “a Buy” for TMDX stock.
Analyzing TMDX Stock Performance
During the last five days, there has been a surge of approximately 7.39%. Over the course of the year, Transmedics Group Inc shares have jumped approximately 17.48%. Shares of the company reached a 52-week high of $177.37 on 08/23/24 and a 52-week low of $69.43 on 03/25/24. A 50-day SMA is recorded $127.92, while a 200-day SMA reached $122.41. Nevertheless, trading volume fell to 1.79 million shares from 1.67 million shares the previous day.
Support And Resistance Levels for Transmedics Group Inc (TMDX)
According to the 24-hour chart, there is a support level at 90.39, which, if violated, would cause prices to drop to 88.06. In the upper region, resistance lies at 96.97. The next price resistance is at 101.22. RSI (Relative Strength Index) is 34.90 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.72, which suggests the price will decrease in the coming days. Percent R is at 76.38%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
